Euro vs US Dollar

Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

Registrieren

HOTH Hoth Therapeutics Inc

0,89

-0,01 (-1,11%)

26 Jun 2024 - Geschlossen

Verzögert um 15 Minuten

Form ARS - Annual Report to Security Holders

Hoth Therapeutics (NASDAQ:HOTH)
Historical Stock Chart
Von Mai 2024 bis Jun 2024

Click Here for more Hoth Therapeutics Charts.

Hoth Therapeutics (NASDAQ:HOTH)
Historical Stock Chart
Von Jun 2023 bis Jun 2024

Click Here for more Hoth Therapeutics Charts.

News Hoth Therapeutics Inc

Form ARS - Annual Report to Security Holders
Dienstag 18 Juni 2024 (1 Woche vor) • Edgar (US Regulatory)

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Dienstag 18 Juni 2024 (1 Woche vor) • Edgar (US Regulatory)

Form DEF 14A - Other definitive proxy statements
Dienstag 18 Juni 2024 (1 Woche vor) • Edgar (US Regulatory)

Form 8-K - Current report
Montag 17 Juni 2024 (1 Woche vor) • Edgar (US Regulatory)

Hoth Therapeutics Announces Joint Development Agreement with Wise Systems International SRL to Utilize Artificial Intelligence for Drug Discovery
Montag 10 Juni 2024 (2 Wochen vor) • PR Newswire (US)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Dienstag 14 Mai 2024 (1 Monat vor) • Edgar (US Regulatory)

Hoth Therapeutics to Attend EF Hutton Annual Global Conference, May 15, 2024
Mittwoch 1 Mai 2024 (2 Monate vor) • PR Newswire (US)

Hoth Therapeutics Announces Exercise of Warrants for $4.2 Million Gross Proceeds
Mittwoch 27 März 2024 (3 Monate vor) • PR Newswire (US)

Hoth Therapeutics' Wholly Owned Subsidiary Merveille.ai, Advances AI-Driven Discovery for Obesity Treatment
Mittwoch 27 März 2024 (3 Monate vor) • PR Newswire (US)

Hoth Therapeutics Announces Positive Data In Completed Study of Alzheimer's Disease Pre-Clinical Treatment with HT-ALZ
Dienstag 19 März 2024 (3 Monate vor) • PR Newswire (US)

Hoth Therapeutics Retains Venable LLP to Expand Its Patent Portfolio
Donnerstag 29 Februar 2024 (4 Monate vor) • PR Newswire (US)

Hoth Therapeutics Engages Altasciences to Perform Key Study for HT-KIT Cancer Fighting Therapeutic
Montag 26 Februar 2024 (4 Monate vor) • PR Newswire (US)

Weitere Hoth Therapeutics Inc News-Artikel

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen